142 related articles for article (PubMed ID: 11695839)
1. Effect of testosterone replacement therapy on serum PSA in patients with Klinefelter syndrome.
Shibasaki T; Sasagawa I; Suzuki Y; Yazawa H; Ichiyanagi O; Matsuki S; Miura M; Nakada T
Arch Androl; 2001; 47(3):173-6. PubMed ID: 11695839
[TBL] [Abstract][Full Text] [Related]
2. Prostate volume and growth during testosterone replacement therapy is related to visceral obesity in Klinefelter syndrome.
Selice R; Caretta N; Di Mambro A; Torino M; Palego P; Ferlin A; Foresta C
Eur J Endocrinol; 2013 Dec; 169(6):743-9. PubMed ID: 24001894
[TBL] [Abstract][Full Text] [Related]
3. Effects of gonadotropin and testosterone treatments on prostate volume and serum prostate specific antigen levels in male hypogonadism.
Ozata M; Bulur M; Beyhan Z; Sengül A; Saglam M; Turan M; Corakci A; Ali Gundogan M
Endocr J; 1997 Oct; 44(5):719-24. PubMed ID: 9466329
[TBL] [Abstract][Full Text] [Related]
4. Prostate cancer following testosterone replacement in Klinefelter syndrome.
Bydder SA; Joseph DJ; Weinstein S; Stuckey BG
ANZ J Surg; 2007; 77(1-2):93-4. PubMed ID: 17295832
[TBL] [Abstract][Full Text] [Related]
5. Testosterone replacement therapy and prostate/seminal vesicle volume in Klinefelter's syndrome.
Sasagawa I; Nakada T; Kazama T; Terada T; Katayama T
Arch Androl; 1989; 22(3):245-9. PubMed ID: 2502953
[TBL] [Abstract][Full Text] [Related]
6. Safety and efficacy of testosterone replacement therapy in adolescents with Klinefelter syndrome.
Mehta A; Clearman T; Paduch DA
J Urol; 2014 May; 191(5 Suppl):1527-31. PubMed ID: 24679877
[TBL] [Abstract][Full Text] [Related]
7. Prostate cancer in Klinefelter syndrome during hormonal replacement therapy.
Hwang JJ; Dharmawardana PG; Uchio EM; Wynberg J; Phillips JL
Urology; 2003 Nov; 62(5):941. PubMed ID: 14624928
[TBL] [Abstract][Full Text] [Related]
8. [Testosterone level not significantly correlates to endothelial progenitor cells in Klinefelter's syndrome patients].
Ru BZ; Gao XC; Yue WW; Hu P
Zhonghua Nan Ke Xue; 2012 Jan; 18(1):67-9. PubMed ID: 22295853
[TBL] [Abstract][Full Text] [Related]
9. Effect of testosterone replacement therapy on bone mineral density in patients with Klinefelter syndrome.
Jo DG; Lee HS; Joo YM; Seo JT
Yonsei Med J; 2013 Nov; 54(6):1331-5. PubMed ID: 24142635
[TBL] [Abstract][Full Text] [Related]
10. Correlation between simultaneous PSA and serum testosterone concentrations among eugonadal, untreated hypogonadal and hypogonadal men receiving testosterone replacement therapy.
Grober ED; Lamb DJ; Khera M; Murthy L; Lipshultz LI
Int J Impot Res; 2008; 20(6):561-5. PubMed ID: 18843272
[TBL] [Abstract][Full Text] [Related]
11. Prostate-specific antigen (PSA) concentrations in hypogonadal men during 6 years of transdermal testosterone treatment.
Raynaud JP; Gardette J; Rollet J; Legros JJ
BJU Int; 2013 May; 111(6):880-90. PubMed ID: 23294726
[TBL] [Abstract][Full Text] [Related]
12. Effect of growth hormone (GH) and/or testosterone replacement on the prostate in GH-deficient adult patients.
Colao A; Di Somma C; Spiezia S; Filippella M; Pivonello R; Lombardi G
J Clin Endocrinol Metab; 2003 Jan; 88(1):88-94. PubMed ID: 12519835
[TBL] [Abstract][Full Text] [Related]
13. Effect of sex hormone treatment on circulating adiponectin and subforms in Turner and Klinefelter syndrome.
Høst C; Bojesen A; Frystyk J; Flyvbjerg A; Christiansen JS; Gravholt CH
Eur J Clin Invest; 2010 Mar; 40(3):211-9. PubMed ID: 20100236
[TBL] [Abstract][Full Text] [Related]
14. Effects of depot testosterone therapy on serum levels of luteinizing hormone and follicle-stimulating hormone in patients with Klinefelter's syndrome and hypogonadotropic eunuchoidism.
Fukutani K; Isurugi K; Takayasu H; Wakabayashi K; Tamaoki B
J Clin Endocrinol Metab; 1974 Nov; 39(5):856-64. PubMed ID: 4418679
[No Abstract] [Full Text] [Related]
15. Successful testicular sperm retrieval in adolescents with Klinefelter syndrome treated with at least 1 year of topical testosterone and aromatase inhibitor.
Mehta A; Bolyakov A; Roosma J; Schlegel PN; Paduch DA
Fertil Steril; 2013 Oct; 100(4):970-4. PubMed ID: 23830150
[TBL] [Abstract][Full Text] [Related]
16. Testosterone and the child (0-12 years) with Klinefelter syndrome (47XXY): a review.
Fennoy I
Acta Paediatr; 2011 Jun; 100(6):846-50. PubMed ID: 21284716
[TBL] [Abstract][Full Text] [Related]
17. Changes in prostate specific antigen in hypogonadal men after 12 months of testosterone replacement therapy: support for the prostate saturation theory.
Khera M; Bhattacharya RK; Blick G; Kushner H; Nguyen D; Miner MM
J Urol; 2011 Sep; 186(3):1005-11. PubMed ID: 21788049
[TBL] [Abstract][Full Text] [Related]
18. Influence of demographic factors and biochemical characteristics on the prostate-specific antigen (PSA) response to testosterone replacement therapy.
Rhoden EL; Morgentaler A
Int J Impot Res; 2006; 18(2):201-5. PubMed ID: 16177827
[TBL] [Abstract][Full Text] [Related]
19. Dutasteride in men receiving testosterone therapy: a randomised, double-blind study.
Kacker R; Harisaran V; Given L; Miner M; Rittmaster R; Morgentaler A
Andrologia; 2015 Mar; 47(2):148-52. PubMed ID: 24499051
[TBL] [Abstract][Full Text] [Related]
20. The effect of testosterone replacement therapy on prostate-specific antigen (PSA) levels in men being treated for hypogonadism: a systematic review and meta-analysis.
Kang DY; Li HJ
Medicine (Baltimore); 2015 Jan; 94(3):e410. PubMed ID: 25621688
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
